Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
Launched by YALE UNIVERSITY · Jan 7, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the effects of cannabis, specifically a compound called Delta-9-Tetrahydrocannabinol (THC), may differ between men and women. Researchers want to understand how these differences might happen in healthy people. The trial is currently looking for participants aged between 18 and 65 who have tried cannabis at least once and are in good physical and mental health. People who have never used cannabis or are currently facing major stressors won’t be eligible to join.
If you decide to participate, you will be part of a study that explores these differences in a controlled setting. This could involve taking THC and then reporting how you feel afterward. The information gathered will help researchers learn more about how gender may influence the effects of cannabis. It’s an important step in understanding how different people react to this substance, which can lead to better health information and treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least one lifetime exposure to cannabis
- • Good physical and mental health
- Exclusion Criteria:
- • Cannabis naïve individuals
- • Major current or recent stressors
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
West Haven, Connecticut, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials